Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advate CI vs BI in Hemophilia A Surgery
NCT00357656Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2006
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started May 2006; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00357656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357656.